| Blastic Plasmacytoid Dendritic Cell Neoplasm |
0 |
1 |
| Skin Cancer |
0 |
0.99 |
| Acute Leukemia |
0 |
0.35 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.34 |
| Acute Myeloblastic Leukemia |
0 |
0.31 |
| Chronic Myelogenous Leukemia |
0 |
0.24 |
| Biopsy |
0 |
0.23 |
| Bone Marrow Transplant |
0 |
0.23 |
| Leukemia |
0 |
0.23 |
| Bone Marrow |
0 |
0.22 |
| Cancer |
0 |
0.21 |
| Myelodysplastic Syndrome |
0 |
0.21 |
| Acute Lymphoblastic Leukemia |
0 |
0.19 |
| Leukemia Cutis |
0 |
0.19 |
| Lymphoma |
0 |
0.19 |
| Neoplasm |
0 |
0.19 |
| Cutaneous Lymphoma |
0 |
0.17 |
| Bone |
0 |
0.15 |
| California |
0 |
0.15 |
| T-Lymphocyte |
0 |
0.15 |
| Biologic Therapy |
0 |
0.13 |
| Stem Cell Research and Therapy |
0 |
0.12 |
| Merkel Cell Carcinoma |
0 |
0.09 |
| Blood |
0 |
0.08 |
| Central Nervous System |
0 |
0.08 |
| Chemotherapy |
0 |
0.08 |
| Lymph Node |
0 |
0.08 |
| Natural Killer (NK) Cells |
0 |
0.08 |
| Prognosis |
0 |
0.08 |
| Transplantation |
0 |
0.08 |
| Systemic Lupus Erythematosus |
0 |
0.06 |
| Antigens |
0 |
0.04 |
| Antiviral Agents |
0 |
0.04 |
| Child |
0 |
0.04 |
| Clinical Guidelines |
0 |
0.04 |
| Clinical Pathology |
0 |
0.04 |
| Diphtheria |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Lupus |
0 |
0.04 |
| Mycosis Fungoides |
0 |
0.04 |
| Nodule |
0 |
0.04 |
| Referral |
0 |
0.04 |
| Scleroderma |
0 |
0.04 |
| Skin Lesion |
0 |
0.04 |
| Systemic Sclerosis |
0 |
0.04 |
| Tdap Vaccine |
0 |
0.04 |